But there’s a powerful fundamental story happening with Abbott Laboratories. Also, EPS is estimated to ramp higher this year by +10.8%. Now it makes sense why the stock has been powering to new ...

incorporated in the year 1944, is a Large Cap company (having a market cap of Rs 62,772.35 Crore) operating in Pharmaceuticals sector. Abbott India Ltd. key Products/Revenue Segments include ...